Cargando…
Evaluation of a New Survivin ELISA and UBC(®) Rapid for the Detection of Bladder Cancer in Urine
Urine-based biomarkers for non-invasive diagnosis of bladder cancer are urgently needed. No single marker with sufficient sensitivity and specificity has been described so far. Thus, a combination of markers appears to be a promising approach. The aim of this case-control study was to evaluate the p...
Autores principales: | Gleichenhagen, Jan, Arndt, Christian, Casjens, Swaantje, Meinig, Carmen, Gerullis, Holger, Raiko, Irina, Brüning, Thomas, Ecke, Thorsten, Johnen, Georg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796175/ https://www.ncbi.nlm.nih.gov/pubmed/29324722 http://dx.doi.org/10.3390/ijms19010226 |
Ejemplares similares
-
Exploring solid-phase proximity ligation assay for survivin detection in urine
por: Gleichenhagen, Jan, et al.
Publicado: (2022) -
Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of malignant mesothelioma using liquid biopsies
por: Weber, Daniel G., et al.
Publicado: (2020) -
Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study
por: Casjens, Swaantje, et al.
Publicado: (2017) -
UBC(®)
Rapid Test—A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study
por: Ecke, Thorsten H., et al.
Publicado: (2018) -
Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis
por: Weber, Daniel G., et al.
Publicado: (2014)